EHA 2020: Updated results of a phase II trial investigating tafasitamab combined with lenalidomide for treatment of relapsed diffuse large b-cell lymphoma.
Home / Resource Library / Tafasitamab Plus Lenalidomide Demonstrates Long-Term Efficacy in R/R DLBCL